乐播传媒

CU Boulder Today鈥擟hemists at CU Boulder have developed a new way to recycle a common type of plastic found in soda bottles and other packaging and are working with Venture Partners at CU Boulder to bring it to real-world applications. The team鈥檚 method relies on electricity and some nifty chemical reactions, and it鈥檚 simple enough that you can watch the plastic break apart in front of your eyes.

CU Boulder Today鈥擨n 2016, Pfizer began collaborating with Sabrina Spencer, a global leader in time-lapse cell imaging and member of the CU Cancer Center, to study how cancer cells respond to their potent new drugs called CDK2 inhibitors.

CU Boulder researchers have identified a surprising new player in ALS (amyotrophic lateral sclerosis)鈥攁n ancient, virus-like protein. With funding from the ALS Association, the National Institutes of Health, and Venture Partners at CU Boulder, Alexandra Whiteley's lab is now working to understand the molecular pathways involved and to find a way of inhibiting the rogue protein.

NIST鈥擱esearchers at the National Institute of Standards and Technology (NIST) and CU Boulder have fabricated a novel device that could dramatically boost the conversion of heat into electricity. If perfected, the technology could help recoup some of the recoverable heat energy that is wasted in the U.S. at a rate...

Interesting Engineering鈥擳he primary goal of soft robotics is to achieve smooth and complex movement by mimicking the locomotion of soft bodies found in the environment. Researchers at CU Boulder and CU Boulder startup Artimus Robotics are leading innovation with a new type of "artificial muscle" to enable life-like movements.

Say 鈥渉ello鈥� to the robots of the future: They鈥檙e soft and flexible enough to bounce off walls or squeeze into tight spaces. And when you鈥檙e done with them, you can toss these machines into a compost bin to decompose.

Scientists from CU Boulder and the National Institute of Standards and Technology (NIST) made an important leap forward in the quest to diagnose disease using exhaled breath, reporting that a new laser-based breathalyzer鈥攂orn of Nobel Prize-winning technology from CU鈥攑owered by artificial intelligence (AI) can detect COVID-19 in real-time with excellent accuracy.

Endpoints News鈥擮nKure Therapeutics has lined up $60 million in a new private funding round, adding to the CU Boulder spinout鈥檚 bank account as it works through a Phase II trial. The startup is attempting to create an inhibitor of histone deacetylases, or HDACs, which are DNA-manipulating enzymes that alter how genes get expressed.

Wanted: entrepreneurs ready to launch startups based on innovations created in CU Boulder鈥檚 research labs. The Embark Deep Tech Startup Creator is a new program created by Venture Partners at CU Boulder, the commercialization arm of CU, to match business minds outside the university with breakthrough inventions created within its walls.

As a first-generation college student turned molecular biologist, Brian DeDecker imagines a day when humble soybeans beans, which his family has grown for generations, pack a bounty of therapeutic but hard-to-obtain natural compounds.